Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.

Youssef RF, Shariat SF, Kapur P, Kabbani W, Ghoneim T, King E, Cockburn A, Mosbah A, Abol-Enein H, Ghoneim M, Lotan Y.

Hum Pathol. 2011 Mar;42(3):347-55. doi: 10.1016/j.humpath.2010.07.012. Epub 2010 Nov 26.

PMID:
21111452
2.

Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.

Youssef R, Kapur P, Shariat SF, Arendt T, Kabbani W, Mosbah A, Abol-Enein H, Ghoneim M, Lotan Y.

BJU Int. 2012 Oct;110(7):961-6. doi: 10.1111/j.1464-410X.2012.10949.x. Epub 2012 Feb 28.

3.

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.

Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP.

J Clin Oncol. 2004 Mar 15;22(6):1014-24. Epub 2004 Feb 23.

PMID:
14981102
4.

Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.

Shariat SF, Zlotta AR, Ashfaq R, Sagalowsky AI, Lotan Y.

Mod Pathol. 2007 Apr;20(4):445-59. Epub 2007 Mar 2.

5.

Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers.

Kapur P, Lotan Y, King E, Kabbani W, Mitra AP, Mosbah A, Abol-Enein H, Ghoneim M, Youssef RF.

Am J Clin Pathol. 2011 Jun;135(6):822-30. doi: 10.1309/AJCP76KUVOTBKQRY.

PMID:
21571954
6.

Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.

Shariat SF, Youssef RF, Gupta A, Chade DC, Karakiewicz PI, Isbarn H, Jeldres C, Sagalowsky AI, Ashfaq R, Lotan Y.

J Urol. 2010 May;183(5):1744-50. doi: 10.1016/j.juro.2010.01.018. Epub 2010 Mar 17.

PMID:
20299037
8.

Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.

Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F.

Cancer. 2004 Jun 1;100(11):2367-75.

9.

Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.

Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y.

Hum Pathol. 2006 Dec;37(12):1568-76. Epub 2006 Aug 10.

PMID:
16949911
10.
11.

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.

Shariat SF, Karakiewicz PI, Ashfaq R, Lerner SP, Palapattu GS, Cote RJ, Sagalowsky AI, Lotan Y.

Cancer. 2008 Jan 15;112(2):315-25.

12.

Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder.

Patschan O, Shariat SF, Chade DC, Karakiewicz PI, Ashfaq R, Lotan Y, Hotakainen K, Stenman UH, Bjartell A.

World J Urol. 2012 Dec;30(6):785-94. doi: 10.1007/s00345-011-0727-7. Epub 2011 Jul 8.

PMID:
21739120
13.
14.

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer.

Stein JP, Ginsberg DA, Grossfeld GD, Chatterjee SJ, Esrig D, Dickinson MG, Groshen S, Taylor CR, Jones PA, Skinner DG, Cote RJ.

J Natl Cancer Inst. 1998 Jul 15;90(14):1072-9.

PMID:
9672255
15.

Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.

Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.

J Urol. 2009 Jul;182(1):78-84; discussion 84. doi: 10.1016/j.juro.2009.02.125. Epub 2009 May 17. Erratum in: J Urol. 2015 May;193(5):1730.

PMID:
19447418
17.

Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.

Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y.

J Urol. 2007 Feb;177(2):481-7; discussion 487.

PMID:
17222615
18.

Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.

Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E, Patsouris E.

Hum Pathol. 2005 Aug;36(8):899-907.

PMID:
16112007
19.

Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.

Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, Arriaga Y, Bolenz C, Margulis V, Raj GV, Sagalowsky AI, Shariat SF.

Eur Urol. 2013 Sep;64(3):465-71. doi: 10.1016/j.eururo.2013.03.043. Epub 2013 Apr 3.

PMID:
23571005
20.

Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.

Bandoh N, Hayashi T, Takahara M, Kishibe K, Ogino T, Katayama A, Imada M, Nonaka S, Harabuchi Y.

Acta Otolaryngol. 2005 Jul;125(7):779-85.

PMID:
16012042

Supplemental Content

Support Center